- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The contraindications of Tazemetostat involve specific populations, dietary interactions, and treatment restrictions, and must be strictly foll...
Tazemetostat is an EZH2 methyltransferase inhibitor primarily used to treat tumors with specific gene mutations. Its indications include epithe...
Tazemetostat, as an EZH2 methyltransferase inhibitor, commonly has side effects involving hematological toxicity, gastrointestinal reactions, a...
Pazopanib is a multi-target tyrosine kinase inhibitor primarily used for the treatment of advanced renal cell carcinoma and soft tissue sarcoma...
Pazopanib, as a multi-target tyrosine kinase inhibitor, commonly has side effects including liver toxicity, hypertension, and hematological abn...
Tofacitinib, as a JAK inhibitor, requires special attention to the risk of infection, cardiovascular events, and serious adverse reactions such...
Tofacitinib is a JAK inhibitor primarily used to treat autoimmune diseases such as rheumatoid arthritis. Its contraindications include severe i...
Erdafitinib, as an FGFR inhibitor, commonly has side effects such as hyperphosphatemia, ocular lesions, and gastrointestinal reactions, which n...
Erdafitinib is an FGFR kinase inhibitor used to treat specific types of advanced urothelial carcinoma. Attention should be paid to adverse reac...
The side effects of Semaglutide tablets mainly involve gastrointestinal reactions and metabolic abnormalities, and most symptoms can be relieve...
